Indo Us Bio-Tech Limited (NSE:INDOUS)
India · Delayed Price · Currency is INR 91.21
+1.55 (1.73%)
Jun 19, 2026, 3:30 PM IST
Indo Us Bio-Tech Revenue
In the fiscal year ending March 31, 2026, Indo Us Bio-Tech had annual revenue of 1.10B INR with 6.36% growth. Indo Us Bio-Tech had revenue of 260.25M in the quarter ending March 31, 2026, a decrease of -22.05%.
Revenue
1.10B
Revenue Growth
+6.36%
P/S Ratio
1.64
Revenue / Employee
n/a
Employees
883
Market Cap
1.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.10B | 66.01M | 6.36% |
| Mar 31, 2025 | 1.04B | 310.02M | 42.56% |
| Mar 31, 2024 | 728.36M | 110.92M | 17.96% |
| Mar 31, 2023 | 617.45M | 116.86M | 23.34% |
| Mar 31, 2022 | 500.59M | 99.48M | 24.80% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nagarjuna Fertilizers and Chemicals | 13.49B |
| Ramdevbaba Solvent | 8.29B |
| Indogulf Cropsciences | 7.12B |
| Nath Bio-Genes (India) | 4.45B |
| TBI Corn | 3.05B |
| Nova Agritech | 2.62B |
| ShreeOswal Seeds and Chemicals | 2.48B |
| Upsurge Seeds Of Agriculture | 1.33B |
Indo Us Bio-Tech News
- 1 year ago - Indo US Bio-Tech share price surges 3% after signing MoU for Pratap Hybrid Maize -6 - Business Upturn